The EPI-PHARE Scientific Interest Group, created at the end of 2018 by ANSM and CNAM, conducts, pilots and coordinates pharmaco-epidemiology studies to enlighten public authorities in their decision-making and meets the growing demand for studies based on the complex and massive data of the French National Health Data System (SNDS).